Handelsavisen
prelaunch
Companies Healthcare COO.O
CO
COO.O NASDAQ Health Care Equipment & Supplies

Cooper Companies Inc

$74,28
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
14,6B USD
P/E
EV / Rev
Div yield
Op margin
16,7 %
ROE
4,5 %
Net margin
9,2 %
Debt / equity
0,30
Beta
52w range
Volume
Day range
Prev close
$70,29
Open
$70,82
Next earnings
2026-08-28
Ex-dividend
TR 1Y
About

The Cooper Companies operates in the Health Care Equipment & Supplies industry, generating revenue through its subsidiaries including CooperVision and CooperSurgical, which provide vision care and surgical products globally.

Business. The Cooper Companies Inc (COO.O) is a health care equipment and supplies manufacturer that operates within the Health Care sector. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability
4,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning COO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to COO.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Cooper Companies Inc (COO.O) has entered the scope of this analysis, marking the first available data point for the ticker with no prior basis for computing historical deltas. As a result, the current snapshot serves as the foundational baseline for future monitoring of the company’s financial and ownership dynamics. The most significant activity observed involves substantial modifications to the holdings of investor ID 587. Data indicates a major shift in share count for this investor as of March 31, 2026, with records showing the position fluctuating between 832 shares and 61,508 shares. These changes, detected in late June and early July 2026, represent a dramatic alteration in the investor's stake, swinging from a negligible weight of approximately 0.00003% to a more substantial 0.25% of the company. In addition to these major modifications, a notable new holding was recorded for investor ID 933. As of September 30, 2022, this investor held 86,091 shares, representing a portfolio weight of roughly 3.37%. This addition highlights ongoing interest from institutional or significant holders, contributing to the broader landscape of the company's shareholder base. Cooper Companies Inc currently maintains a profile with one listed officer and membership in one index, supported by a top holder count of 37. With zero analyst coverage currently recorded, the company’s valuation and outlook rely heavily on these ownership signals and fundamental data rather than consensus estimates. The recent volatility in major holder positions underscores the importance of monitoring these shifts as key indicators of investor sentiment.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The Cooper Companies Inc (COO.O) is a health care equipment and supplies manufacturer that operates within the Health Care sector. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Equipment & Supplies
    AI synthesis
    GENERATED

    The company maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating limited leverage relative to shareholder equity. Total liabilities stand at $4.16 billion against total assets of $12.39 billion, resulting in a net debt position after accounting for $110.6 million in cash and equivalents. The current liquidity profile is assessed as medium risk, supported by operating cash flow of $796.1 million, which comfortably covers capital expenditures of $362.4 million. The price-to-book ratio of 1.63 suggests the market values the company slightly above its tangible book value, while the EV/EBITDA multiple of 23.09 reflects a premium valuation relative to earnings before interest, taxes, depreciation, and amortization.

    Profitability metrics indicate modest returns, with a return on equity of 4.55% and a return on assets of 3.02%. The net income of $374.9 million represents a net margin of approximately 9.16% on revenue of $4.09 billion. Operating income of $682.9 million suggests effective cost control, yielding an operating margin of roughly 16.7%. These returns are generated from a gross profit of $2.68 billion, implying a gross margin of approximately 65.5%, which is typical for specialized medical device and consumable manufacturers. The valuation snapshot shows a P/E ratio of 35.8, indicating that investors are pricing in future growth expectations despite current moderate return metrics.

    Revenue generation is supported by a global network of subsidiaries, including CooperVision Sarl, CooperVision RUS LLC, CooperVision Israel Ltd, and CooperSurgical, Inc. The presence of entities in Russia, Israel, and other international jurisdictions suggests significant geographic diversification beyond the domestic market. The subsidiary structure indicates a fragmented operational footprint that likely serves distinct regional markets for contact lenses, surgical instruments, and other health care supplies. This global exposure provides revenue stability but also introduces operational complexity across different regulatory environments.

    Growth trajectory analysis is limited by the absence of historical period data in the current input. However, the current revenue base of $4.09 billion provides a substantial scale for incremental growth. The company’s ability to maintain positive operating cash flow of $796.1 million suggests resilience in cash generation, which can be reinvested into R&D or used for share repurchases. Without historical trend data, the sustainability of current revenue levels must be inferred from the stability of the balance sheet and the consistent generation of operating income.

    Risk assessment highlights medium liquidity risk and low dilution risk. The key flag notes that net cash is negative after subtracting total debt, which is a standard condition for leveraged firms but requires monitoring of interest coverage. The low dilution risk is supported by the identical basic and diluted share counts of 195.9 million, indicating no significant outstanding options or convertible securities that would erode shareholder value in the near term. The primary financial risk lies in the management of long-term debt of $2.46 billion, which must be serviced by operating cash flows.

    Recent observations include reconciler events indicating zero analysis jobs for the company, which is an internal processing note rather than a business event. The IR observations confirm the corporate structure through EDGAR filings, listing various subsidiaries with high confidence. There are no specific news events, filing observations, or transcript observations provided that indicate recent strategic shifts, mergers, or regulatory actions. The absence of recent material news suggests a stable operational environment without immediate catalysts or disruptions.

    Cooper Companies Inc (COO.O) has entered the scope of this analysis, marking the first available data point for the ticker with no prior basis for computing historical deltas. As a result, the current snapshot serves as the foundational baseline for future monitoring of the company’s financial and ownership dynamics. The most significant activity observed involves substantial modifications to the holdings of investor ID 587. Data indicates a major shift in share count for this investor as of March 31, 2026, with records showing the position fluctuating between 832 shares and 61,508 shares. These changes, detected in late June and early July 2026, represent a dramatic alteration in the investor's stake, swinging from a negligible weight of approximately 0.00003% to a more substantial 0.25% of the company. In addition to these major modifications, a notable new holding was recorded for investor ID 933. As of September 30, 2022, this investor held 86,091 shares, representing a portfolio weight of roughly 3.37%. This addition highlights ongoing interest from institutional or significant holders, contributing to the broader landscape of the company's shareholder base. Cooper Companies Inc currently maintains a profile with one listed officer and membership in one index, supported by a top holder count of 37. With zero analyst coverage currently recorded, the company’s valuation and outlook rely heavily on these ownership signals and fundamental data rather than consensus estimates. The recent volatility in major holder positions underscores the importance of monitoring these shifts as key indicators of investor sentiment.

    Key takeaways
    • The company generates $4.09 billion in revenue with a strong gross margin of ~65.5%, driven by its vision care and surgical product segments.
    • Leverage is conservative with a debt-to-equity ratio of 0.3, though net cash is negative due to $2.46 billion in long-term debt.
    • Returns are modest with ROE at 4.55% and ROA at 3.02%, trading at a premium P/E of 35.8 and EV/EBITDA of 23.09.
    • Dilution risk is low, as basic and diluted share counts are identical at 195.9 million shares.
    • Global subsidiary structure indicates diversified geographic exposure, including entities in Russia and Israel, which may introduce geopolitical considerations.
    • Operating cash flow of $796.1 million exceeds capital expenditures of $362.4 million, providing free cash flow for debt service or reinvestment.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $74,28
    Market cap
    $13.42B
    Enterprise value
    $15.77B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    19.8x
    P / B
    1.6x
    P / Tangible book
    1.6x
    Tangible book
    $8.24B
    Net cash
    -$2.35B
    Current ratio
    Debt / equity
    0.3
    ROA
    3.0%
    ROE
    4.5%
    Cash conversion
    212.0%
    CapEx / revenue
    8.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships77 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries77
    EX21:0302f34ee7dbEX21:0302f34ee7dbSubsidiarie97%
    EX21:07271b69e8a3EX21:07271b69e8a3Subsidiarie97%
    EX21:0b1971fb724eEX21:0b1971fb724eSubsidiarie97%
    EX21:129643a9f564EX21:129643a9f564Subsidiarie97%
    EX21:136abe115d85EX21:136abe115d85Subsidiarie97%
    EX21:193ad2e757d1EX21:193ad2e757d1Subsidiarie97%
    EX21:1b0020a6efd6EX21:1b0020a6efd6Subsidiarie97%
    EX21:1b512c1cdd84EX21:1b512c1cdd84Subsidiarie97%
    EX21:1fefeba9c137EX21:1fefeba9c137Subsidiarie97%
    EX21:24cacf5004bfEX21:24cacf5004bfSubsidiarie97%
    EX21:25d2a8f194d3EX21:25d2a8f194d3Subsidiarie97%
    EX21:2972d25ac245EX21:2972d25ac245Subsidiarie97%
    EX21:2aeb6f1f0d1eEX21:2aeb6f1f0d1eSubsidiarie97%
    EX21:2c0b1c9cba7fEX21:2c0b1c9cba7fSubsidiarie97%
    EX21:2fd347cc8855EX21:2fd347cc8855Subsidiarie97%
    EX21:332e4d15cc0fEX21:332e4d15cc0fSubsidiarie97%
    EX21:33b37225a8f9EX21:33b37225a8f9Subsidiarie97%
    EX21:35c4f7811392EX21:35c4f7811392Subsidiarie97%
    EX21:3c671602500fEX21:3c671602500fSubsidiarie97%
    EX21:4128567abb42EX21:4128567abb42Subsidiarie97%
    EX21:41be696300c1EX21:41be696300c1Subsidiarie97%
    EX21:41d75b199a7aEX21:41d75b199a7aSubsidiarie97%
    EX21:426edea403a6EX21:426edea403a6Subsidiarie97%
    EX21:43076b28e086EX21:43076b28e086Subsidiarie97%
    EX21:44fcc2d473f5EX21:44fcc2d473f5Subsidiarie97%
    EX21:4519a0d61d30EX21:4519a0d61d30Subsidiarie97%
    EX21:46eb6aaf5d8aEX21:46eb6aaf5d8aSubsidiarie97%
    EX21:481dcc050068EX21:481dcc050068Subsidiarie97%
    EX21:4a49440ca94bEX21:4a49440ca94bSubsidiarie97%
    EX21:4a930384774dEX21:4a930384774dSubsidiarie97%
    EX21:4c30cc9ad474EX21:4c30cc9ad474Subsidiarie97%
    EX21:561cfe11bcb2EX21:561cfe11bcb2Subsidiarie97%
    EX21:6252af63bc12EX21:6252af63bc12Subsidiarie97%
    EX21:6363190bc095EX21:6363190bc095Subsidiarie97%
    EX21:6a1060d31d15EX21:6a1060d31d15Subsidiarie97%
    EX21:6ae2112978d6EX21:6ae2112978d6Subsidiarie97%
    EX21:6ae880f0f8eeEX21:6ae880f0f8eeSubsidiarie97%
    EX21:6df249cbfec4EX21:6df249cbfec4Subsidiarie97%
    EX21:6e6ddd152f44EX21:6e6ddd152f44Subsidiarie97%
    EX21:703c3631212fEX21:703c3631212fSubsidiarie97%
    EX21:749180edc221EX21:749180edc221Subsidiarie97%
    EX21:78d5528e8567EX21:78d5528e8567Subsidiarie97%
    EX21:791a015025eeEX21:791a015025eeSubsidiarie97%
    EX21:801f3f653e9bEX21:801f3f653e9bSubsidiarie97%
    EX21:85a82fd76707EX21:85a82fd76707Subsidiarie97%
    EX21:87af7e6bcacbEX21:87af7e6bcacbSubsidiarie97%
    EX21:90b11eac7038EX21:90b11eac7038Subsidiarie97%
    EX21:992c9c522623EX21:992c9c522623Subsidiarie97%
    EX21:9abd5e9fcc3bEX21:9abd5e9fcc3bSubsidiarie97%
    EX21:9ca5e6333896EX21:9ca5e6333896Subsidiarie97%
    EX21:9cc6b6d221e7EX21:9cc6b6d221e7Subsidiarie97%
    EX21:a21b51c10dddEX21:a21b51c10dddSubsidiarie97%
    EX21:a4fbc98ccd02EX21:a4fbc98ccd02Subsidiarie97%
    EX21:a5e8479037efEX21:a5e8479037efSubsidiarie97%
    EX21:a8c01494bc9dEX21:a8c01494bc9dSubsidiarie97%
    EX21:beb101d9cdd5EX21:beb101d9cdd5Subsidiarie97%
    EX21:c226925fcde1EX21:c226925fcde1Subsidiarie97%
    EX21:c418c9e86923EX21:c418c9e86923Subsidiarie97%
    EX21:c714dd4591bfEX21:c714dd4591bfSubsidiarie97%
    EX21:cc5175386e8aEX21:cc5175386e8aSubsidiarie97%
    EX21:cdc672fee7caEX21:cdc672fee7caSubsidiarie97%
    EX21:ced142fc5418EX21:ced142fc5418Subsidiarie97%
    EX21:d0a76bcb35afEX21:d0a76bcb35afSubsidiarie97%
    EX21:d1bdef41bc57EX21:d1bdef41bc57Subsidiarie97%
    EX21:d3e95fc59a5eEX21:d3e95fc59a5eSubsidiarie97%
    EX21:deb7c824bd40EX21:deb7c824bd40Subsidiarie97%
    EX21:e17efd383ce7EX21:e17efd383ce7Subsidiarie97%
    EX21:e215a0a1e27aEX21:e215a0a1e27aSubsidiarie97%
    EX21:e848e564551fEX21:e848e564551fSubsidiarie97%
    EX21:e9e728be5bf1EX21:e9e728be5bf1Subsidiarie97%
    EX21:eac11e2c6403EX21:eac11e2c6403Subsidiarie97%
    EX21:ef88f1a29081EX21:ef88f1a29081Subsidiarie97%
    EX21:f139a73be65bEX21:f139a73be65bSubsidiarie97%
    EX21:f33187e1e46eEX21:f33187e1e46eSubsidiarie97%
    EX21:f5432748175aEX21:f5432748175aSubsidiarie97%
    EX21:fc8ba27fbfaeEX21:fc8ba27fbfaeSubsidiarie97%
    EX21:ff14e23d964fEX21:ff14e23d964fSubsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate4,63
    Revenueno estimateno estimate4,3B USD
    Operating incomeno estimateno estimate1,1B USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-28 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-01

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution18 analysts
    Strong buy5
    Buy5
    Hold8
    Sell0
    Strong sell0
    12-month price target$83,49 · Median $85,00
    Low $66,00High $92,00
    Operating income · consensus1,1B USD
    EPS surprise
    −11,0 %
    reported vs consensus · miss
    Revenue surprise
    −5,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$66,00
    Mean$83,49
    Median$85,00
    High$92,00
    Spot$74,28
    +12.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin16,7 %Above P75
    Net Margin9,2 %Above median
    ROE4,5 %Above median
    Capex / Rev8,9 %Best in class
    D/E0,30Below median
    Cash Conv2,12Above P75

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-28 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 123 404 sh22 exercises · 16 grants14 insiders
    • Keel Paul ADirector · Restricted Stock Units → Common StockAcquired 2 814grant · 2026-07-01
    • Kurzius Lawrence ErikDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Rosebrough Walter M JrDirector · Restricted Stock Units → Common StockDisposed 832exercise · 2026-04-01
    • WEISS ROBERT SDirector · Restricted Stock Units → Common StockDisposed 3 654exercise · 2026-04-01
    • WEISS ROBERT SDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Rivas MariaDirector · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
    • Rivas MariaDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Jay ColleenDirector · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
    • Jay ColleenDirector · Restricted Stock Units → Common StockAcquired 4 157grant · 2026-04-01
    • Carbone BarbaraDirector · Restricted Stock Units → Common StockDisposed 3 050exercise · 2026-04-01
    • Carbone BarbaraDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Rosebrough Walter M JrDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • MADDEN TERESA SDirector · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
    • MADDEN TERESA SDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Lucchese Cynthia LDirector · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
    • Lucchese Cynthia LDirector · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
    • Kurzius Lawrence ErikDirector · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
    • Jay ColleenDirector · Stock Options (Right to Buy) → Common StockDisposed 7 064 @ $39,40exercise · 2026-01-12
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Restricted Stock Units → Common StockDisposed 1 232exercise · 2026-01-08
    • Andrews Brian GEVP, CFO & Treasurer · Restricted Stock Units → Common StockDisposed 3 528exercise · 2026-01-08
    • McBride Daniel GEVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 163exercise · 2026-01-08
    • McBride Daniel GEVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 556exercise · 2026-01-08
    • McBride Daniel GEVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 168exercise · 2026-01-08
    • Sheffield Holly RPresident, CSI · Restricted Stock Units → Common StockDisposed 3 154exercise · 2026-01-08
    • Sheffield Holly RPresident, CSI · Restricted Stock Units → Common StockDisposed 3 304exercise · 2026-01-08

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • The Cooper Companies, Inc. Market data — financials · 2026-07-28
    • reconciler_enqueue (reconciler) on COO.O · 2026-07-28
    • Cooper Companies Inc HA canonical relationships · 2026-07-28

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,45 %$1M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,12 %$261M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,11 %$219M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,09 %$348M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,08 %$152M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,07 %$530M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,07 %$211M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,04 %$241M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,04 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,04 %$246M
    • Invesco QQQ TrustFunds · as of 2026-03-310,04 %$261M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,03 %$1 519M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,03 %$0M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,03 %$148M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,03 %$1 930M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,02 %$378M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,02 %$81M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,02 %$627M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,02 %$129M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,02 %$88M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,02 %$127M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,02 %$54M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$79M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,01 %$20M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,01 %$39M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,01 %$17M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,01 %$137M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$57M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,01 %$9M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,01 %$16M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$10M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$4M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$4M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$35M
    • Fisher InvestmentsInvestment Managers · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Albert G. WhitePresident, Chief Executive Officer, Director

    Insider activity

    Net buying5 buys · 0 sellsnet $1,3M13 insiders · last 365d
    • Rivas MariaDirector · Common StockOther 3 322 · 2026-04-01
    • Kurzius Lawrence ErikDirector · Common StockOther 3 322 · 2026-04-01
    • Lucchese Cynthia LDirector · Common StockOther 3 322 · 2026-04-01
    • MADDEN TERESA SDirector · Common StockOther 3 322 · 2026-04-01
    • Carbone BarbaraDirector · Common StockOther 3 050 · 2026-04-01
    • Jay ColleenDirector · Common StockOther 3 322 · 2026-04-01
    • Rosebrough Walter M JrDirector · Common StockOther 832 · 2026-04-01
    • WEISS ROBERT SDirector · Common StockOther 3 654 · 2026-04-01
    • Jay ColleenDirector · Common StockOther 7 064 @ $39,40$278K · 2026-01-12
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 1 540 · 2026-01-08
    • White Albert G IIIDirector, President & CEO · Common StockOther 18 340 · 2026-01-08
    • White Albert G IIIDirector, President & CEO · Common StockOther 9 419 @ $83,13$783K · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 2 652 · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 3 154 · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 1 232 · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 2 940 · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 1 714 @ $83,13$142K · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 629 @ $83,13$52K · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 787 @ $83,13$65K · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 1 501 @ $83,13$125K · 2026-01-08
    • Warner Gerard H IIIPresident, CooperVision, Inc. · Common StockOther 1 354 @ $83,13$113K · 2026-01-08
    • Sheffield Holly RPresident, CSI · Common StockOther 3 154 · 2026-01-08
    • Sheffield Holly RPresident, CSI · Common StockOther 1 592 · 2026-01-08
    • Sheffield Holly RPresident, CSI · Common StockOther 3 304 · 2026-01-08
    • Sheffield Holly RPresident, CSI · Common StockOther 1 462 @ $83,13$122K · 2026-01-08

    Short positioning

    7.9Mshares short+6.7% vs prior
    3.1days to cover
    49.8%short of daily vol
    578fails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    COO.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorM&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    COOEX21:030EX21:072EX21:0b1EX21:129EX21:136EX21:193EX21:1b0EX21:1b5EX21:1feEX21:24cHealth Care Eq
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Long-term debt (annual): USD 1.88BUnknown
    • Shares outstanding (annual): 195.1MUnknown
    • Cash & equivalents (annual): USD 124.9MUnknown
    • Total liabilities (annual): USD 4.06BUnknown
    • Total assets (annual): USD 12.42BUnknown
    • Shareholders' equity (annual): USD 8.36BUnknown
    • Current liabilities (annual): USD 1.6BUnknown
    • Current assets (annual): USD 2.13BUnknown
    • Gross profit (annual): USD 2.68BUnknown
    • Operating cash flow (annual): USD 796.1MUnknown
    • Net income (annual): USD 374.9MUnknown
    • Operating income (annual): USD 682.9MUnknown
    • Revenue (annual): USD 4.09BUnknown
    • Capex (annual): USD 362.4MUnknown
    • Cost of revenue (annual): USD 1.41BUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 2Unknown
    • Pre-tax income (annual): USD 566.5MUnknown
    • EPS (basic) (annual): USD-PER-SHARES 2Unknown
    • R&D expense (annual): USD 172.2MUnknown
    • Long-term debt (annual): USD 2.49BUnknown
    • Shareholders' equity (annual): USD 8.13BUnknown
    • Shares outstanding (annual): 199.9MUnknown
    • Current liabilities (annual): USD 999.6MUnknown
    • Current assets (annual): USD 1.99BUnknown
    Showing 24 of 36 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-03 03:12 UTCHOLDERInstitutional holding changed
    2026-07-03 03:12 UTCHOLDER1 institutional position change flagged (1 major)
    2026-07-01 03:10 UTCHOLDERInstitutional holding changed
    2026-07-01 03:10 UTCHOLDER1 institutional position change flagged (1 major)
    2026-07-01INSIDERKeel Paul A acquired 2.8k sh Restricted Stock Units — Director
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDER1 institutional position change flagged
    2026-06-24 03:12 UTCHOLDERInstitutional holding changed
    2026-06-24 03:12 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-23 03:11 UTCHOLDERInstitutional holding changed
    2026-06-23 03:11 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-05FILING10-Q filing →
    2026-06-04FILING8-K filing →
    2026-05-04FILING8-K filing →
    2026-04-08FILING8-K filing →
    2026-04-01 00:00 UTCINSIDER24 insider transactions — 2026-04 16 derivative
    2026-04-01 00:00 UTCINSIDER24 insider transactions — 2026-04 16 derivative
    2026-04-01INSIDERRivas Maria transacted 3.3k sh — Director
    2026-04-01INSIDERKurzius Lawrence Erik transacted 3.3k sh — Director
    2026-04-01INSIDERLucchese Cynthia L transacted 3.3k sh — Director
    2026-04-01INSIDERMADDEN TERESA S transacted 3.3k sh — Director
    2026-04-01INSIDERCarbone Barbara transacted 3.0k sh — Director
    2026-04-01INSIDERJay Colleen transacted 3.3k sh — Director
    2026-04-01INSIDERRosebrough Walter M Jr transacted 832 sh — Director
    2026-04-01INSIDERWEISS ROBERT S transacted 3.7k sh — Director
    2026-04-01INSIDERKurzius Lawrence Erik acquired 3.8k sh Restricted Stock Units — Director
    2026-04-01INSIDERRosebrough Walter M Jr disposed of 832 sh Restricted Stock Units — Director
    2026-04-01INSIDERWEISS ROBERT S disposed of 3.7k sh Restricted Stock Units — Director
    2026-04-01INSIDERWEISS ROBERT S acquired 3.8k sh Restricted Stock Units — Director
    2026-04-01INSIDERRivas Maria disposed of 3.3k sh Restricted Stock Units — Director
    2026-04-01INSIDERRivas Maria acquired 3.8k sh Restricted Stock Units — Director
    2026-04-01INSIDERJay Colleen disposed of 3.3k sh Restricted Stock Units — Director
    2026-04-01INSIDERJay Colleen acquired 4.2k sh Restricted Stock Units — Director
    2026-04-01INSIDERCarbone Barbara disposed of 3.0k sh Restricted Stock Units — Director
    2026-04-01INSIDERCarbone Barbara acquired 3.8k sh Restricted Stock Units — Director
    2026-04-01INSIDERRosebrough Walter M Jr acquired 3.8k sh Restricted Stock Units — Director
    2026-04-01INSIDERMADDEN TERESA S disposed of 3.3k sh Restricted Stock Units — Director
    2026-04-01INSIDERMADDEN TERESA S acquired 3.8k sh Restricted Stock Units — Director
    Showing the 40 most recent of 70 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage